Twelve-month treatment with Liraglutide ameliorates Visceral Adiposity Index and common cardiovascular risk factors in type 2 diabetes outpatients.
Academic Article
Publication Date:
2014
Iris type:
14.a.1 Articolo su rivista
List of contributors:
Russo GT;Labate AM;Giandalia A;Elisabetta L Romeo;Villari P;Alibrandi A;Perdichizzi G;Cucinotta D
Published in: